Company Breathtec Biomedical Inc Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Chief Operating Officer | 41 | 21-02-28 | |
Ahmad Khalil
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 21-09-07 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
Mark Williams
BRD | Director/Board Member | 52 | 21-09-21 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Raj Attariwala
BRD | Director/Board Member | 55 | 15-10-25 |
Howard Gutman
BRD | Director/Board Member | - | 22-02-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,840,722 | 21,665,319 ( 99.20 %) | 0 | 99.20 % |
Company contact information
Algernon Pharmaceuticals, Inc.
601 West Broadway Street Suite 400
V5Z 4C2, Vancouver
+604-398-4175
http://www.algernonpharmaceuticals.comSector
1st Jan change | Capi. | |
---|---|---|
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |